桂枝茯苓丸治疗子宫肌瘤的临床疗效研究  

Discussion on the clinical effect of Guizhi Fuling Pills in the treatment of hysteromyoma

作　　者：吴海霞 王瑛坚[1] 苑家林 胡宇博[1] WU Haixia;WANG Yingjian;YUAN Jialin;HU Yubo(China-Japan Union Hospital of Jilin University,Changchun 130033,China)

机构地区：[1]吉林大学中日联谊医院,长春130033

出　　处：《长春中医药大学学报》2021年第2期362-364,共3页Journal of Changchun University of Chinese Medicine

基　　金：吉林省科技厅白求恩专项(440020032086)。

摘　　要：目的观察桂枝茯苓丸治疗子宫肌瘤的临床效果。方法选取子宫肌瘤患者80例,随机分成对照组和治疗组,各40例。对照组予米非司酮治疗,治疗组在对照组的基础上予桂枝茯苓丸治疗。对比2组的临床疗效、子宫肌瘤平均体积的变化以及不良反应发生情况。结果治疗组总有效率(90%,36/40)优于对照组(75%,30/40)(P<0.05);治疗前后2组子宫肌瘤体积均有减小,且治疗组优于对照组(P<0.05);2组不良反应发生情况差异不明显。结论联合桂枝茯苓丸治疗与单纯使用米非司酮治疗比较,可以有效提高临床疗效,缩小子宫肌瘤体积。Objective To observe the clinical effect of Guizhi Fuling Pills in the treatment of hysteromyoma.Methods A total of 80 patients with hysteromyoma were selected and randomly divided into control group and treatment group,with 40 cases in each group.The control group was treated with mifepristone,and the treatment group was treated with Guizhi Fuling Pills on the basis of the control group.The clinical efficacy,the change in the average volume of hysteromyoma,and the probability of adverse reactions were compared between the two groups.Results The total effective rate of the treatment group(90%,36/40)was better than that of the control group(75%,30/40)(P<0.05).The volume of hysteromyoma in both groups was reduced after treatment,and the treatment group was better than the control group(P<0.05).There was no significant difference in adverse reactions between the two groups.Conclusion The combined treatment with Guizhi Fuling Pills can effectively improve the clinical efficacy and reduce the volume of hysteromyoma compared with the treatment with mifepristone alone.

关 键 词：子宫肌瘤 桂枝茯苓丸 临床疗效 

分 类 号：R737.33[医药卫生—肿瘤]